Search results
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than...
Fortune· 6 hours agoHims said it’s offering a treatment with the same active ingredient as Wegovy for $199 a month. This will help customers access these drugs without “navigating the shortages and costs that are ...
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
InvestorPlace· 10 hours agoHims & Hers has partnered with an undisclosed manufacturer of generic and 503B compounded injectable...
Hims & Hers is getting into the weight-loss drug game — and Wall Street is loving it
INSIDER via Yahoo News· 8 hours agoHims & Hers' stock surged more than 30% on Monday in response to the news...brand-name versions —...
Trendy SF wellness company unveils cheap copycat of Ozempic
San Francisco Chronicle· 6 hours agoHims & Hers Health has grown into a telehealth giant by making it easier to order generic versions...
Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade
InvestorPlace· 5 days agoSeveral drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 16 hours agoMerck also has some key new products lined up for launch. Between 2025 and 2030, Merck...
Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates
Zacks· 7 days agoThis quarterly report represents an earnings surprise of 9.09%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. , which belongs to ...
Israel’s Once-Dominant Drugmaker Is Revived by Innovation
The Wall Street Journal via Yahoo Finance· 7 days agoMost ...capitalization of about $18 billion. Last Wednesday, thecompany reaffirmed its 2024 guidance...
ADHD drug shortage shows signs of letting up, but some patients still struggle
NBC News via Yahoo News· 2 days agoADHD medication shortages have largely been resolved, says the FDA. However, some doctors and...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 6 days agoThe company also calls for adjusted earnings of $13.50 to $14 a share. Both measures...to bring in...